Life Science Virtual Investor Forum Agenda Announced for September 18th

The Life Science Virtual Investor Forum is set to take place on September 18, 2025, bringing together individual and institutional investors, along with analysts and advisors, to explore the latest innovations in the life sciences sector. Co-hosted by Zacks SCR and organized by Virtual Investor Conferences, this event emphasizes direct engagement between investors and emerging companies.

The agenda features presentations from notable companies in the industry, including Amplia Therapeutics (Pink: INNMF | ASX: ATX), Kelyniam Global (OTCID: KLYG), and United Health Products (OTCQB: UEEC), among others. Starting promptly at 9:30 AM ET, the forum will host various company presentations, allowing stakeholders to understand the vision and strategies driving these organizations. Each presentation is structured to deliver insights into the companies' operations, innovations, and future potential.

Participants can also take advantage of the opportunity to arrange one-on-one meetings with management teams, providing a personalized platform for deeper discussions. The event offers complimentary access to presentations and individual meetings, making it an inclusive experience for all interested investors.

Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group, expressed enthusiasm about the event, highlighting its role in fostering investor relationships and showcasing cutting-edge developments in life sciences.

Investors are encouraged to pre-register and complete a system check to smooth the login process. With the forum commencing at 9:30 AM ET and concluding at 4:00 PM ET, it aims to deliver a comprehensive overview of the life science landscape, encouraging meaningful connections and informed investment decisions.

For further details, interested parties can visit the Virtual Investor Conferences' website.

The upcoming Life Science Virtual Investor Forum on September 18, 2025, presents a unique opportunity for investors to gain insights into several innovative companies within the life sciences sector. This virtual event, co-hosted by Zacks SCR, allows attendees to deepen their understanding of emerging trends and developments influencing healthcare and biotechnology, all from the convenience of their desktop or mobile devices.

Investors should take advantage of this forum by pre-registering to ensure they have access to live presentations and the ability to engage in one-on-one meetings with company management, a feature that can significantly enhance the investment decision-making process. The participation is complimentary, reinforcing the platform's intent to democratize access to vital industry information.

Among the companies slated to present, it is noteworthy to keep an eye on those that have recently experienced fluctuations in their stock prices or have upcoming catalysts such as product launches or regulatory approvals. For instance, companies like Dermata Therapeutics, Inc., which trades on NASDAQ, could be particularly interesting for those seeking exposure to the dermatology sector, while Kelyniam Global, Inc., known for its innovative healthcare solutions, may appeal to investors looking for growth in medical technology.

Moreover, since many of these stocks trade on the OTC markets, it's prudent for investors to conduct rigorous due diligence, understanding that while these opportunities can yield substantial returns, they also carry a heightened risk profile.

In summary, this virtual conference serves as a rich resource for investors eager to navigate the burgeoning life science landscape. Engaging with company representatives directly can unveil new insights and assist investors in making informed decisions. Monitoring the outcomes of this event may potentially influence trading strategies in the life sciences space moving forward.